Physician-prescribed GLP-1 therapy with personalized dosing, available nationwide
Water/Aqua/Eau, Octyldodecyl Neopentanoate, Cetearyl Alcohol, Caprylic/Capric Triglyceride, Dimethicone, Glycerin, Sodium Polystyrene Sulfonate, Behenyl Alcohol, Hydrogenated Vegetable Glycerides, Butyrospermum Parkii (Shea) Butter, Glyceryl Stearate, PEG-100 Stearate, Polysorbate 20, Diheptyl Succinate, Phenoxyethanol, Steareth-20, Butylene Glycol, Capryloyl Glycerin/Sebacic Acid Copolymer, Macadamia Ternifolia Seed Oil, S-Palmitoylglutathione, Salvia Hispanica Seed Oil, Silica, Xanthan Gum, Fucus Vesiculosus Extract, Ethylhexylglycerin, Linum Usitatissimum (Linseed) Seed Oil, Disodium EDTA, Sodium Hydroxide, Lactic Acid, Hexylene Glycol, Cryptomeria Japonica Bud Extract, Caprylyl Glycol, Tocopherol, Iron Oxides (CI 77491), Titanium Dioxide (CI 77891) Gently pat onto eye area using your ring finger
At 8mg, the glucagon receptor stimulation is strong enough to produce the tingling and altered skin sensitivity reported in trials
Relaxation Routine: Develop a calming pre-sleep ritual, such as reading a book, taking a warm bath, or listening to calming music
Pharmacokinetics Eight-weeks-old male C57BL/6 mice ( n =3 per group) were injected with a single subcutaneous dose of P5 or Ex4 (100 g kg 1 ), and blood was collected 1, 2, 4, 8 and 24 h later